Insulet (NSDQ:PODD) and Dexcom (NSDQ:DXCM) yesterday floated a joint promotion aimed at luring users of the Animas insulin pump after Johnson & Johnson (NYSE:JNJ) bails out of the insulin pump biz.
The companies are hoping to chip off a piece of the diabetes market from Medtronic (NYSE:MDT), to which J&J has offered to help some 90,000 Animas patients transfer (J&J is also evaluating another of its diabetes businesses, LifeScan, which makes the OneTouch line of blood glucose monitoring products).
Get the full story at our sister site, Drug Delivery Business News.
The post Insulet, Dexcom partner to lure ex-Animas users appeared first on MassDevice.
from MassDevice http://ift.tt/2yy90mU
Cap comentari:
Publica un comentari a l'entrada